Logo image of PSAT.PA

PASSAT (PSAT.PA) Stock Fundamental Analysis

EPA:PSAT - Euronext Paris - Matif - FR0000038465 - Common Stock - Currency: EUR

4.85  -0.14 (-2.81%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PSAT. PSAT was compared to 10 industry peers in the Broadline Retail industry. PSAT has an average financial health and profitability rating. PSAT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year PSAT was profitable.
PSAT had a positive operating cash flow in the past year.
Each year in the past 5 years PSAT has been profitable.
Of the past 5 years PSAT 4 years had a positive operating cash flow.
PSAT.PA Yearly Net Income VS EBIT VS OCF VS FCFPSAT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

PSAT has a worse Return On Assets (1.98%) than 80.00% of its industry peers.
With a Return On Equity value of 3.29%, PSAT is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
The Return On Invested Capital of PSAT (5.31%) is worse than 60.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PSAT is in line with the industry average of 8.96%.
Industry RankSector Rank
ROA 1.98%
ROE 3.29%
ROIC 5.31%
ROA(3y)3.75%
ROA(5y)4.19%
ROE(3y)5.67%
ROE(5y)5.9%
ROIC(3y)7.99%
ROIC(5y)8.11%
PSAT.PA Yearly ROA, ROE, ROICPSAT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8

1.3 Margins

PSAT has a Profit Margin of 2.09%. This is amonst the worse of the industry: PSAT underperforms 80.00% of its industry peers.
PSAT's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 5.08%, PSAT is doing worse than 60.00% of the companies in the same industry.
PSAT's Operating Margin has improved in the last couple of years.
PSAT has a better Gross Margin (57.70%) than 90.00% of its industry peers.
PSAT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.08%
PM (TTM) 2.09%
GM 57.7%
OM growth 3Y-6.22%
OM growth 5Y29.84%
PM growth 3Y-17.46%
PM growth 5Y14.99%
GM growth 3Y-0.15%
GM growth 5Y0.5%
PSAT.PA Yearly Profit, Operating, Gross MarginsPSAT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PSAT is destroying value.
PSAT has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, PSAT has about the same amount of shares outstanding.
PSAT has a worse debt/assets ratio than last year.
PSAT.PA Yearly Shares OutstandingPSAT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
PSAT.PA Yearly Total Debt VS Total AssetsPSAT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.11 indicates that PSAT is not in any danger for bankruptcy at the moment.
PSAT's Altman-Z score of 3.11 is on the low side compared to the rest of the industry. PSAT is outperformed by 60.00% of its industry peers.
PSAT has a debt to FCF ratio of 5.51. This is a neutral value as PSAT would need 5.51 years to pay back of all of its debts.
The Debt to FCF ratio of PSAT (5.51) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.23 indicates that PSAT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.23, PSAT is doing good in the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.51
Altman-Z 3.11
ROIC/WACC0.65
WACC8.11%
PSAT.PA Yearly LT Debt VS Equity VS FCFPSAT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 3.51 indicates that PSAT has no problem at all paying its short term obligations.
PSAT has a better Current ratio (3.51) than 80.00% of its industry peers.
A Quick Ratio of 2.45 indicates that PSAT has no problem at all paying its short term obligations.
PSAT's Quick ratio of 2.45 is fine compared to the rest of the industry. PSAT outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 2.45
PSAT.PA Yearly Current Assets VS Current LiabilitesPSAT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

PSAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.23%.
The Earnings Per Share has been growing by 30.40% on average over the past years. This is a very strong growth
PSAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.52%.
Measured over the past years, PSAT shows a quite strong growth in Revenue. The Revenue has been growing by 13.43% on average per year.
EPS 1Y (TTM)-67.23%
EPS 3Y-0.35%
EPS 5Y30.4%
EPS Q2Q%-125.86%
Revenue 1Y (TTM)16.52%
Revenue growth 3Y20.73%
Revenue growth 5Y13.43%
Sales Q2Q%-3.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PSAT.PA Yearly Revenue VS EstimatesPSAT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

4

4. Valuation

4.1 Price/Earnings Ratio

PSAT is valuated correctly with a Price/Earnings ratio of 14.70.
Compared to the rest of the industry, the Price/Earnings ratio of PSAT indicates a rather cheap valuation: PSAT is cheaper than 90.00% of the companies listed in the same industry.
PSAT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.29.
Industry RankSector Rank
PE 14.7
Fwd PE N/A
PSAT.PA Price Earnings VS Forward Price EarningsPSAT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PSAT indicates a rather cheap valuation: PSAT is cheaper than 100.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PSAT is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.71
EV/EBITDA 1.1
PSAT.PA Per share dataPSAT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.48
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PSAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PASSAT

EPA:PSAT (6/2/2025, 7:00:00 PM)

4.85

-0.14 (-2.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.79%
Ins Owner ChangeN/A
Market Cap20.37M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.7
Fwd PE N/A
P/S 0.32
P/FCF 11.71
P/OCF 5.32
P/B 0.51
P/tB 0.57
EV/EBITDA 1.1
EPS(TTM)0.33
EY6.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.41
FCFY8.54%
OCF(TTM)0.91
OCFY18.79%
SpS14.99
BVpS9.52
TBVpS8.52
PEG (NY)N/A
PEG (5Y)0.48
Profitability
Industry RankSector Rank
ROA 1.98%
ROE 3.29%
ROCE 6.42%
ROIC 5.31%
ROICexc 10.18%
ROICexgc 12.13%
OM 5.08%
PM (TTM) 2.09%
GM 57.7%
FCFM 2.76%
ROA(3y)3.75%
ROA(5y)4.19%
ROE(3y)5.67%
ROE(5y)5.9%
ROIC(3y)7.99%
ROIC(5y)8.11%
ROICexc(3y)14.61%
ROICexc(5y)16.94%
ROICexgc(3y)15.97%
ROICexgc(5y)19.27%
ROCE(3y)9.66%
ROCE(5y)9.81%
ROICexcg growth 3Y-6%
ROICexcg growth 5Y31.7%
ROICexc growth 3Y-4.22%
ROICexc growth 5Y31.57%
OM growth 3Y-6.22%
OM growth 5Y29.84%
PM growth 3Y-17.46%
PM growth 5Y14.99%
GM growth 3Y-0.15%
GM growth 5Y0.5%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.51
Debt/EBITDA 1.64
Cap/Depr 90.08%
Cap/Sales 3.32%
Interest Coverage 250
Cash Conversion 69.4%
Profit Quality 132.22%
Current Ratio 3.51
Quick Ratio 2.45
Altman-Z 3.11
F-Score5
WACC8.11%
ROIC/WACC0.65
Cap/Depr(3y)81.8%
Cap/Depr(5y)87.35%
Cap/Sales(3y)2.54%
Cap/Sales(5y)2.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.23%
EPS 3Y-0.35%
EPS 5Y30.4%
EPS Q2Q%-125.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.52%
Revenue growth 3Y20.73%
Revenue growth 5Y13.43%
Sales Q2Q%-3.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-57.99%
EBIT growth 3Y13.23%
EBIT growth 5Y47.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y145.41%
FCF growth 3Y57.72%
FCF growth 5Y13.84%
OCF growth 1Y242.04%
OCF growth 3Y41.84%
OCF growth 5Y14.68%